Integrated Dementia Care Interventions for Alzheimer's and Dementia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve care for people living with dementia and their caregivers by testing different support strategies. Researchers are examining three main interventions: Emergency Care Redesign (ECR), Nurse-led Telephonic Care (NLTC), and Community Paramedic-led Transitions Intervention (CPTI). These interventions aim to connect participants with community services, enhance the quality of care, and reduce hospital visits. Suitable candidates for this trial are individuals aged 66 or older who have been diagnosed with Alzheimer's or a related dementia and have recently visited the emergency department. As an unphased trial, this study allows participants to contribute to innovative care strategies that could enhance support for dementia patients and their caregivers.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the treatments in this study aim to assist people with dementia and their caregivers. These treatments are designed to smooth the transition from emergency care to home care and enhance the overall care experience.
The Community Paramedic-led Transitions Intervention (CPTI) has undergone previous testing. It focuses on reducing unnecessary hospital visits by providing care at home, easing and securing the shift from hospital to home.
The Emergency Care Redesign (ECR) targets individuals with dementia. It has been implemented in several emergency departments to enhance care delivery. The goal is to better meet the needs of dementia patients, and early results suggest it is well-received.
The Nurse-led Telephonic Care (NLTC) involves regular phone calls from nurses to support patients and caregivers. Previous studies have shown that this approach can improve quality of life and reduce stress.
All three treatments are designed to be safe and supportive for people with dementia. They aim to provide better care without adding stress or causing harm. While specific safety data for these interventions are not detailed, their focus on improving care rather than introducing new medical treatments suggests a lower risk of side effects.12345Why are researchers excited about this trial?
Researchers are excited about these interventions for Alzheimer's and dementia because they offer fresh approaches to patient care. Unlike traditional treatments that mainly focus on medication, these interventions emphasize innovative care methods. The Community Paramedic-led Transitions Intervention (CPTI) aims to smooth the transition from hospital to home, potentially reducing readmissions. Emergency Care Redesign (ECR) seeks to improve how emergency care is delivered, making it more efficient and tailored to dementia patients' needs. Lastly, Nurse-led Telephonic Care (NLTC) provides ongoing support through phone calls, enhancing patient monitoring and caregiver support. These methods are designed to improve overall care quality and patient outcomes in ways that current standard treatments may not fully address.
What evidence suggests that this trial's treatments could be effective for dementia care?
Research shows that the Community Paramedic-led Transitions Intervention (CPTI), one of the interventions in this trial, helps people with dementia transition from the emergency room to home more smoothly. This program offers personalized help from paramedics, which has improved care and reduced future hospital visits. Another intervention, Emergency Care Redesign (ECR), aims to change emergency room services to better serve dementia patients, and studies suggest this can decrease the likelihood of returning to the emergency room. Nurse-led Telephonic Care (NLTC), also tested in this trial, provides phone support, effectively helping caregivers manage dementia symptoms and easing their caregiving responsibilities. Together, these programs focus on improving the quality of care and satisfaction for both patients and their caregivers.12467
Who Is on the Research Team?
Joshua Chodosh, MD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for people aged 66 and older diagnosed with Alzheimer's or related dementias, who have had multiple health visits for these conditions. Their care partners must be adults over 18. It's not open to patients under the age of 66.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive different combinations of interventions focused on improving emergency and post-emergency care for persons living with dementia and their care partners.
Follow-up
Participants are monitored for safety and effectiveness after interventions, focusing on transitional care, quality of care, and reduction in future ED visits and hospitalizations.
What Are the Treatments Tested in This Trial?
Interventions
- Community Paramedic-led Transitions Intervention (CPTI)
- Emergency Care Redesign (ECR)
- Nurse-led Telephonic Care (NLTC)
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Institute on Aging (NIA)
Collaborator